Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Globus Medical Inc (GMED)

Globus Medical Inc (GMED)
70.00 x 1 73.56 x 1
Post-market by (Cboe BZX)
71.01 -0.13 (-0.18%) 04/17/25 [NYSE]
70.00 x 1 73.56 x 1
Post-market 71.01 unch (unch) 16:07 ET
Profile for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Globus Medical Inc 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 USA

www.globusmedical.com Employees: 5,300 P: 610-930-1800 F: 610-930-2042

Sector:

Medical

Description:

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.

Key Statistics

Overview:

Market Capitalization, $K 9,784,738
Enterprise Value, $K 9,443,648
Shares Outstanding, K 137,542
Annual Sales, $ 2,519 M
Annual Net Income, $ 102,980 K
Last Quarter Sales, $ 657,290 K
Last Quarter Net Income, $ 26,510 K
EBIT, $ 285,360 K
EBITDA, $ 780,800 K
60-Month Beta 1.28
% of Insider Shareholders 18.54%
% of Institutional Shareholders 95.16%
Float, K 112,042
% Float 81.46%
Short Volume Ratio 0.63

Growth:

1-Year Return 38.69%
3-Year Return 3.62%
5-Year Return 51.86%
5-Year Revenue Growth 220.79%
5-Year Earnings Growth 80.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.84 on 02/20/25
Next Earnings Date 05/06/25 [--]
Earnings Per Share ttm 3.14
EPS Growth vs. Prev Qtr 1.20%
EPS Growth vs. Prev Year 40.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GMED Ratios

Ratio
Price/Earnings ttm 23.04
Price/Earnings forward 20.99
Price/Earnings to Growth 1.84
Return-on-Equity % 10.71%
Return-on-Assets % 8.53%
Profit Margin % 4.09%
Debt/Equity 0.11
Price/Sales 3.95
Price/Cash Flow 10.86
Price/Book 2.38
Book Value/Share 30.40
Interest Coverage -1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro